The global eubiotics market size reached USD 4.9 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 8.9 Billion by 2033, exhibiting a growth rate (CAGR) of 6.26% during 2025-2033. Rising awareness of animal health and nutritional benefits of eubiotics along with rising global demand for quality livestock products are propelling eubiotics market growth. In line with this, strict regulation on antibiotic growth promoters further enhances the adoption of eubiotics in animal feed, thereby supporting its market growth.
Report Attribute
|
Key Statistics
|
---|---|
Base Year
|
2024 |
Forecast Years
|
2025-2033
|
Historical Years
|
2019-2024
|
Market Size in 2024 | USD 4.9 Billion |
Market Forecast in 2033 | USD 8.9 Billion |
Market Growth Rate (2025-2033) | 6.26% |
Rising Demand for Natural Products
The gradual shift towards natural and non-antibiotic alternatives in animal feed is mainly driven by the rising concerns about antibiotic resistance which is a significant public health issue. According to a report published by the Centers for Disease Control and Prevention, antibiotic resistance is one of the top threats to public health. In the United States, antibiotic resistance causes more than 2 million infections and 23,000 deaths per year. Eubiotics mainly comprising probiotics, prebiotics and organic acids offer a great alternative to antibiotics. Eubiotics help enhance gut health and bolster the immune system in livestock without contributing to antibiotic resistance. Its ability to improve animal health and performance sustainability is positioning eubiotics as an important component in the future of animal husbandry and feed formulations.
Increase in Regulatory Support
Governments globally are increasingly implementing strict regulations on antibiotic use in animal agriculture to combat the growing threat of antibiotic resistance. These regulations aim to limit the routine use of antibiotics that can promote resistance among bacteria. In 2017, the FDA prohibited the use of antibiotics for growth promotion in animals. The antibiotic drugs could only be obtained with a veterinarian's prescription, no longer over the counter. Such regulatory measures are driving the demand for alternative solutions like eubiotics, which include probiotics, prebiotics, and organic acids that naturally enhance animal health and performance without contributing to antibiotic resistance. This regulatory environment supports a shift toward more sustainable and responsible animal farming practices, thereby driving eubiotics market growth.
Expansion in Emerging Markets
As emerging markets in Asia-Pacific, Latin America, and some parts of Africa experience rapid modernization and gradual growth in their agricultural sectors, there's a marked increase in the adoption of advanced animal feed solutions like eubiotics. This growth is particularly evident in livestock production and aquaculture, where the need for sustainable and efficient practices is becoming increasingly important. According to a report published by the Department of Animal Husbandry and Dairying, there are about 303.76 million bovines (cattle, buffalo, mithun, and yak), 74.26 million sheep, 148.88 million goats, 9.06 million pigs, and about 851.81 million poultry as per 20th Livestock Census in the country. Eubiotics, known for enhancing gut health and improving overall animal immunity, are being adopted as essential components of animal nutrition programs, which in turn is propelling the eubiotics demand.
IMARC Group provides an analysis of the key trends in each segment of the market, along with forecasts at the global, regional, and country levels for 2025-2033. Our report has categorized the market based on product, form, application and end-use.
Breakup by Product:
Probiotics accounts for the majority of the market share
The report has provided a detailed breakup and analysis of the market based on the product. This includes probiotics, prebiotics, organic acids, essential oils, and others. According to the report, prebiotics represented the largest segment.
Probiotics hold a significant majority of the eubiotics market share, primarily due to their well-documented benefits in promoting gut health and enhancing immunity in livestock. The effectiveness of probiotics in improving feed conversion ratios, increasing growth rates, and reducing disease incidence has been widely recognized by the livestock industry. As regulatory pressures mount against the use of antibiotics, probiotics are increasingly viewed as a viable, natural alternative. The EU banned routine use of antibiotics for animals and restricted preventative use in January 2022. The UK had planned to align with the EU regulations and now commits to "similar provisions" in its 5-year action plan update. Continuous innovations in probiotic strains and delivery methods also support their market dominance.
Breakup by Form:
Solid holds the largest share of the industry
A detailed breakup and analysis of the market based on the Form have also been provided in the report. This includes liquid, and solid. According to the report, solid accounted for the largest market share.
Solid eubiotics are the most popular form in the eubiotics industry due to their ease of handling, stability, and longer shelf life. They are preferred for their convenience in storage and transportation, and for their ability to withstand varying environmental conditions without losing their effectiveness. Manufacturers prefer producing solid eubiotics because they can be easily mixed with other feed components, ensuring uniform distribution in feed. This form is widely adopted across various types of livestock feed, further consolidating their dominant market position.
Breakup by Application:
Gut Health represents the leading market segment
The report has provided a detailed breakup and analysis of the market based on the application. This includes gut health, immunity, yield, and others. According to the report, git health represented the largest segment.
Gut health represents the leading market segment within the eubiotics industry, driven by the critical role that gut microbiota plays in overall animal health and productivity. Eubiotics such as probiotics, prebiotics, and organic acids are extensively utilized to enhance gut flora, improve digestion, and boost immune responses in livestock. This segment's dominance is underscored by increasing evidence linking gut health to better feed efficiency, reduced disease incidence, and enhanced growth performance in animals. As producers continue to seek natural solutions for maintaining animal health, particularly in the face of restrictions on antibiotic growth promoters, the focus on gut health solutions is expected to sustain robust market growth in this segment.
Breakup by End-Use:
Poultry Feed exhibits a clear dominance in the market
A detailed breakup and analysis of the market based on the end-use have also been provided in the report. This includes cattle feed, poultry feed, swine feed, aquafeed, and others. According to the report, poultry feed accounted for the largest market share.
Poultry feed exhibits clear dominance in the eubiotics market, primarily because poultry is one of the most widely farmed animals globally, driven by rising consumer demand for poultry meat and eggs. The intensive nature of poultry farming necessitates robust health management practices, where eubiotics play a crucial role in enhancing gut health and preventing disease. The use of eubiotics in poultry feed not only improves feed conversion rates and growth performance but also supports the industry's shift away from antibiotic growth promoters. Additionally, with the global expansion of poultry production, particularly in emerging markets, the demand for eubiotics in poultry feed is expected to continue growing, reinforcing its dominant position in the market.
Breakup by Region:
Europe leads the market, accounting for the largest eubiotics market share
The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, Europe represents the largest regional market for eubiotics.
Europe leads the eubiotics market due to its strict regulations against antibiotics in animal feed. The region promotes animal welfare and food safety by encouraging the use of natural alternatives, driving demand for eubiotics. In addition, European consumers are highly aware of sustainable and ethical animal farming practices. Europe's advanced agricultural technologies and significant investments in research and development of feed additives also contribute to its market leadership. Horizon Europe, with a budget of €95.5 billion, is Europe's primary funding program for research and innovation. These factors make Europe both a significant consumer and innovator in the eubiotics sector.
Report Features | Details |
---|---|
Base Year of the Analysis | 2024 |
Historical Period | 2019-2024 |
Forecast Period | 2025-2033 |
Units | Billion USD |
Scope of the Report | Exploration of Historical Trends and Market Outlook, Industry Catalysts and Challenges, Segment-Wise Historical and Future Market Assessment:
|
Products Covered | Probiotics, Prebiotics, Organic Acids, Essential Oils, Others |
Forms Covered | Liquid, Solid |
Applications Covered | Gut Health, Immunity, Yield, Others |
End-Uses Covered | Cattle Feed, Poultry Feed, Swine Feed, Aquafeed, Others |
Regions Covered | Asia Pacific, Europe, North America, Latin America, Middle East and Africa |
Countries Covered | United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico |
Companies Covered | Advanced Bionutrition Corp., Behn Meyer Holding AG, Beneo Gmbh (Sudzucker AG), Calpis Co. Ltd. (Asahi Group Holdings Ltd.), Koninklijke DSM N.V., DuPont de Nemours Inc., Kemin Industries Inc., Lallemand Inc., Lesaffre, Novus International Inc. (Mitsui &Co. Ltd.), UAS Laboratories LLC (Chr. Hansen Holding A/S), etc. |
Customization Scope | 10% Free Customization |
Post-Sale Analyst Support | 10-12 Weeks |
Delivery Format | PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request) |
Key Questions Answered in This Report:
Key Benefits for Stakeholders: